Form 8-K - Current report:
SEC Accession No. 0001087294-13-000019
Filing Date
2013-11-06
Accepted
2013-11-06 17:26:59
Documents
3
Period of Report
2013-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q320138k-earningsrelease.htm 8-K 27247
2 EX 99.1 PRESS RELEASE q32013-ex991earningsrelease.htm EX-99.1 200305
3 cumberlandpharmaceuti_image1.jpg GRAPHIC 37721
  Complete submission text file 0001087294-13-000019.txt   280772
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 131197557
SIC: 2834 Pharmaceutical Preparations